A Multidisciplinary Approach to Rectal Cancer Treatment in Ulcerative Colitis Results in High Rate of Restorative Minimally Invasive Surgery
- 4 August 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Crohn's and Colitis
- Vol. 16 (2) , 244-250
Abstract
Background and Aims: Few recent studies focus on the treatment of rectal cancer in patients with ulcerative colitis. We report treatment options and results for this subset of patients with a multimodal approach at two European referral centres. Methods: Ulcerative colitis patients diagnosed with rectal cancer arising at less than 15 cm from the anal verge between January 2010 and December 2020 were analysed. Demographics, clinical data, and details of medical and surgical treatment were retrieved from prospectively collected institutional databases. Results: Of 132 patients with ulcerative colitis and concomitant colorectal cancer, rectal cancer was diagnosed in 46. The median time between disease onset and rectal cancer diagnosis was 17.5 years; 21/46 were preoperatively staged as early tumours [cT1-T2/N0]. Eleven patients received neoadjuvant chemoradiotherapy for locally advanced extraperitoneal adenocarcinoma, and the rest underwent surgery first. Over two-thirds of the procedures were restorative [68%]; a minimally invasive approach was used in 96% of patients, with no conversion to open. The median follow-up was 44 months. Local recurrence occurred in three patients [6%]. The cumulative 3-year cancer-specific survival rate was 94% [and the 3-year disease-free rate was 86%]. Conclusions: Rectal cancer in ulcerative colitis is a very complex condition. Our results show that surgery for rectal cancer can be delivered with excellent oncological and functional outcomes in patients with ulcerative colitis. A multidisciplinary discussion among surgeons, gastroenterologists, and medical oncologists is key to ensure the appropriate treatment pathway for individual patients.Keywords
This publication has 23 references indexed in Scilit:
- Timing of Surgery After Long-Course Neoadjuvant Chemoradiotherapy for Rectal CancerDiseases of the Colon & Rectum, 2013
- Clinical Features and Oncologic Outcomes in Patients With Rectal Cancer and Ulcerative ColitisDiseases of the Colon & Rectum, 2012
- Dehydration Is the Most Common Indication for Readmission After Diverting Ileostomy CreationDiseases of the Colon & Rectum, 2012
- Immunogenicity of anti-TNF antibodies. Has the veil been lifted?Gut, 2010
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategiesWorld Journal of Gastroenterology, 2008
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerNew England Journal of Medicine, 2004
- Rectal cancer and ulcerative colitis: does it change the therapeutic approach?Colorectal Disease, 2003
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001